APC Anti-G3BP antibody [EPR13985(B)],Abcam,AB303138

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human

Application

IHC-P, ICC/IF, Flow Cyt, Target Binding Affinity, Antibody Labelling

Conjugate

APC

Platform ID

BAB583231852

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAPC Anti-G3BP antibody [EPR13985(B)]
Cat. No.AB303138
HostRabbit
IsotypeIgG
ReactivityHuman
ConjugationAPC
ApplicationIHC-P, ICC/IF, Flow Cyt, Target Binding Affinity, Antibody Labelling
ClonalityMonoclonal
Clone NumberEPR13985(B)
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Storage+4°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Protein involved in various processes, such as stress granule formation and innate immunity (PubMed : 12642610, PubMed : 20180778, PubMed : 23279204, PubMed : 30510222, PubMed : 30804210). Plays an essential role in stress granule formation (PubMed : 12642610, PubMed : 20180778, PubMed : 23279204, PubMed : 32302570, PubMed : 32302571, PubMed : 32302572, PubMed : 34739333, PubMed : 35977029, PubMed : 36183834, PubMed : 36279435, PubMed : 36692217, PubMed : 37379838). Stress granules are membraneless compartments that store mRNAs and proteins, such as stalled translation pre-initiation complexes, in response to stress (PubMed : 12642610, PubMed : 20180778, PubMed : 23279204, PubMed : 27022092, PubMed : 32302570, PubMed : 32302571, PubMed : 32302572, PubMed : 36279435, PubMed : 37379838). Promotes formation of stress granules phase-separated membraneless compartment by undergoing liquid-liquid phase separation (LLPS) upon unfolded RNA-binding : functions as a molecular switch that triggers RNA-dependent LLPS in response to a rise in intracellular free RNA concentrations (PubMed : 32302570, PubMed : 32302571, PubMed : 32302572, PubMed : 34739333, PubMed : 36279435, PubMed : 36692217). Also acts as an ATP- and magnesium-dependent helicase : unwinds DNA/DNA, RNA/DNA, and RNA/RNA substrates with comparable efficiency (PubMed : 9889278). Acts unidirectionally by moving in the 5' to 3' direction along the bound single-stranded DNA (PubMed : 9889278). Unwinds preferentially partial DNA and RNA duplexes having a 17 bp annealed portion and either a hanging 3' tail or hanging tails at both 5'- and 3'-ends (PubMed : 9889278). Plays an essential role in innate immunity by promoting CGAS and RIGI activity (PubMed : 30510222, PubMed : 30804210). Participates in the DNA-triggered cGAS/STING pathway by promoting the DNA binding and activation of CGAS (PubMed : 30510222). Triggers the condensation of cGAS, a process probably linked to the formation of membrane-less organelles (PubMed : 34779554). Also enhances RIGI-induced type I interferon production probably by helping RIGI at sensing pathogenic RNA (PubMed : 30804210). May also act as a phosphorylation-dependent sequence-specific endoribonuclease in vitro : Cleaves exclusively between cytosine and adenine and cleaves MYC mRNA preferentially at the 3'-UTR (PubMed : 11604510). See full target information G3BP1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.